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Abstract
Reperfusion injury results from pathologies of cardiac myocyte physiology that develop when previously ischemic
myocardium experiences a restoration of normal perfusion. Events in the development of reperfusion injury begin with the
restoration of a proton gradient upon reperfusion, which then allows the sodium-proton exchanger (NHE) to increase flux,
removing protons from the intracellular space while importing sodium. The resulting sodium overload drives increased
reverse-mode sodium-calcium exchanger (NCX) activity, creating a secondary calcium overload that has pathologic
consequences. One of the attempts to reduce reperfusion-related damage, NHE inhibition, has shown little clinical benefit,
and only when NHE inhibitors are given prior to reperfusion. In an effort to further understand why NHE inhibitors have
been largely unsuccessful, we employed a new mathematical cardiomyocyte model that we developed for the study of
ischemia and reperfusion. Using this model, we simulated 20 minutes of ischemia and 10 minutes of reperfusion, while also
simulating NHE inhibition by reducing NHE flux in our model by varying amounts and at different time points. In our
simulations, when NHE inhibition is applied at the onset of reperfusion, increasing the degree of inhibition increases the
peak sodium and calcium concentrations, as well as reducing intracellular pH recovery. When inhibition was instituted at
earlier time points, some modest improvements were seen, largely due to reduced sodium concentrations prior to
reperfusion. Analysis of all sodium flux pathways suggests that the sodium-potassium pump (NaK) plays the largest role in
exacerbated sodium overload during reperfusion, and that reduced NaK flux is largely the result of impaired pH recovery.
While NHE inhibition does indeed reduce sodium influx through that exchanger, the resulting prolongation of intracellular
acidosis paradoxically increases sodium overload, largely mediated by impaired NaK function.
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Introduction
Ischemia-reperfusion (IR) injury represents a constellation of
pathological events that occur when previously ischemic
myocardium experiences a restoration of normal tissue perfu-
sion. IR injury, which can manifest as dangerous arrhythmias
such as ventricular tachycardias and fibrillation, reduced
myocardial force development, or an increased region of cell
death, is likely to become even more clinically relevant in coming
years owing to an aging population and the impact of aging on
susceptibility to ischemia/reperfusion injury [1]. As such, it is
desirable to develop an ability to effectively treat and prevent
such phenomena.
Because of the danger that ischemia-reperfusion related events
pose, there has been great interest in this problem for several
decades. A large number of studies, directed at furthering the
understanding of ischemia-reperfusion injury and examining many
potential therapeutic targets, have been undertaken [2–4]. As a
result of these studies, significant insight into the mechanisms of IR
injury has been obtained. Figure 1 illustrates a chain of events that
are believed to play a prominent role in ischemia-reperfusion
injury [3–6]:
1. During ischemia, as the available oxygen is depleted, cells
switch to anaerobic metabolism, with reduced ability to
synthesize ATP. As anaerobic metabolism progresses, meta-
bolic acidosis develops. This acidosis is exacerbated by the rise
in the partial pressure of carbon dioxide in the ischemic region
[7,8]. The sodium-proton exchanger (NHE) attempts to correct
intracellular pH (pHi) by exporting protons and importing
sodium in exchange. Concurrently, decreasing concentrations
of ATP lead to decreased flux through the sodium-potassium
pump (NaK) and increased current through ATP-inactivated
potassium efflux channels (IK(ATP)).
2. Increased NHE flux and decreased NaK activity conspire to
produce an overload of intracellular sodium (Naz
i ). Also,
decreased NaK flux and increased efflux through IK(ATP)
channels produce an elevated concentration of extracellular
potassium (Kz
o ), which carries proarrhythmic consequences
such as shortening of the action potential duration and
PLoS Computational Biology | www.ploscompbiol.org 1 October 2011 | Volume 7 | Issue 10 | e1002241depolarization of the resting membrane potential (RMP). Kz
o
accumulation is also exacerbated by decreased extracellular
volume (not shown).
3. The Naz
i overload is partially relieved by the sodium-calcium
exchanger (NCX) spending more time in reverse mode.
However, increased reverse mode produces a secondary
intracellular calcium (Ca2z
i ) overload. Ca2z
i overload has
been shown to be associated with pro-arrhythmic phenomena
such as alternans [9] and spontaneous calcium releases [10].
Additionally, calcium overload can result in hypercontracture
and cell death [4]. Complicating this scenario are the effects of
acidosis and decreased [ATP] on multiple components of the
calcium handling system. Decreased intracellular pH and/or
[ATP] result in decreased flux through SERCA [8,11–13],
decreased ryanodine receptor release [8,14], and decreased
NCX flux [8,11,15].
4. Upon reperfusion, a washout of the acidic extracellular fluid
occurs, restoring a proton gradient and allowing for increased
NHE activity [2,4].
5. Increased NHE activity results in a second spike in Naz
i ,
exacerbating the Naz
i overload that developed during
ischemia.
6. As during ischemia, this second Naz
i overload results in a
second Ca2z
i overload, especially as inhibition of the calcium-
handling machinery is relaxed. In addition, [Kz
o ] returns to
normal [5] as tissue is reperfused, resulting in a return to
normal resting membrane potential.
While much has been determined about the pathogenesis of
reperfusion injury, we argue that a comprehensive understanding
remains elusive. The most salient point is that despite numerous
studies investigating many potential therapeutic agents to prevent
reperfusion injury, efforts at translation of potential therapies to
clinical practice have been largely unsuccessful [2,3,16].
One approach to treating ischemia-reperfusion injury has been
inhibition of the NHE [2,3], which is attractive for several reasons.
The NHE is potentially responsible for a large amount of sodium
permeability in cardiomyocytes [17]; the rationale is that if NHE
flux is reduced during reperfusion, sodium overload can be
mitigated and hence the secondary calcium overload can be
reduced as well. In addition to reducing sodium and calcium-
mediated reperfusion injury, NHE inhibition has been thought to
play another beneficial role. It is believed that decreased ATP
availability leads to activation of proteases and phospholipases that
result in damage to the cell membrane, but that these enzymes
have reduced activity under the relatively acidotic environment
present during ischemia. Thus, when pH recovers during
reperfusion, these enzymes increase in activity and cause damage.
Therefore, NHE inhibition may reduce injury caused by proteases
and phospholipases [17]. Despite some success in preclinical
studies [4], NHE inhibition has had little beneficial effect in the
clinical setting – when any beneficial effect is observed, it is when
Author Summary
Myocardial ischemia, commonly observed when arteries
supplying the heart become occluded, results when
cardiac tissue receives inadequate blood perfusion. In
order to minimize the amount of cardiac damage, ischemic
tissue must be reperfused. However, reperfusion can result
in deleterious effects that leave the heart muscle sicker
than if the ischemia had been allowed to continue.
Examples of these reperfusion injuries include lethal
arrhythmias and an increased region of cell death. Some
of the early events that result in reperfusion injury include
changes in pH and an overload of sodium inside the cell.
During reperfusion, the sodium-proton exchanger (NHE)
removes protons from the cell in an effort to restore
normal pH, in turn importing sodium ions. Many strategies
have been attempted to prevent reperfusion injury,
including inhibition of the NHE, with little clinical effect.
Using a mathematical model that we developed to study
ischemia and reperfusion in cardiac cells, we found that
NHE inhibition produces more severe sodium overload,
largely due to adverse consequences of the delayed pH
recovery produced by NHE inhibition. These results
suggest that NHE inhibition alone may not be a viable
strategy, and that therapies which prolong intracellular
acidosis may be problematic.
Figure 1. Some events that occur during myocardial ischemia and reperfusion. During ischemia, ATP depletion leads to inhibition of the
sodium-potassium exchanger (NaK) and increased efflux through the ATP-regulated potassium channel (IK(ATP)) (1). Also, increased anaerobic
metabolism produces a metabolic acidosis (1). Increased IK(ATP) and decreased NaK flux contribute to the accumulation of extracellular potassium (2)
(larger font). In addition, intracellular acidosis drives increased flux through the sodium-proton exchanger (NHE), contributing to extracellular acidosis
(larger font) and intracellular sodium accumulation (2), worsened by decreased NaK flux. Increased intracellular sodium results in the sodium-calcium
exchanger (NCX) operating more in the reverse mode, contributing to increased myoplasmic calcium concentration (3). High intracellular calcium
concentrations can lead to abnormal sarcoplasmic reticulum calcium cycling and proarrhythmic phenomena. Upon reperfusion, washout of acidotic,
hyperkalemic extracellular fluid occurs (4), reducing the concentrations of extracellular potassium and protons (smaller font). The resulting proton
gradient allows increased flux through the NHE, resulting in exacerbations of intracellular sodium (5) and calcium (6) overloads (larger font) and
additional proarrhythmic phenomena. Note that numbers in this legend correspond to encircled numbers in figure, not references.
doi:10.1371/journal.pcbi.1002241.g001
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[3,4].
While there are several possible reasons for the failure to
develop an effective treatment for reperfusion injury thus far [3],
the most fundamental may be that cellular systems, not to mention
myocardial tissue consisting of a large number of coupled cells, are
highly coupled systems containing a large number of components,
many exhibiting nonlinear relationships between them. Such
systems are frequently robust to perturbations, often behave non-
intuitively, and likely require observation and/or perturbation of
more than just a couple of components in order to gain an
adequate understanding of processes of interest.
Because of the aforementioned complexities, we aimed to
develop a mathematical model that would enable us and others to
gain insight into events that occur during myocardial ischemia and
reperfusion, and to make predictions about possible therapeutic
strategies. While models of ischemia already exist [6,8,18], none
capture all of the relevant processes discussed above. In addition,
these models were designed to address ischemia only, not
reperfusion. Therefore, based upon experimental data from the
literature, we have developed an improved mathematical model of
the cardiomyocyte, and an accompanying protocol, that allows us
to more realistically simulate myocardial ischemia and reperfusion.
We then used this model to examine NHE inhibition as a
therapeutic strategy. In our simulations, we observed that NHE
inhibition produced no significant improvement in terms of
sodium and calcium overload during reperfusion relative to
control, and in some cases the amount of sodium and calcium
overload was worse than control. In addition, we observed that
NHE inhibition inhibited the recovery from intracellular acidosis
and that the effects of prolonged acidosis on some subcellular
components played a role in the failure to attenuate sodium
overload.
Methods
Mathematical Model
This model (Figure 2) predominantly represents guinea pig
physiology. Representative action potentials are shown in Figure 3.
The starting point for this work was a model previously published
by Crampin and Smith (CS model) [8], which is a charge-
difference implementation of the Luo-Rudy dynamic (LRd) guinea
pig ventricular myocyte model [19] where membrane voltage is
calculated based upon changes in ion concentrations rather than
the transmembrane currents [20,21]. Modifications to the LRd
designed to simulate the effects of respiratory acidosis (Figure 2
(black and green)) were introduced in the CS model, including the
flux of species that are important for pH regulation across the
plasma membrane, as well as dynamic intracellular pH that is
subject to both bicarbonate and ‘‘intrinsic’’ buffering. However,
extracellular pH changes in the CS model depend only on
prescribed extracellular carbon dioxide (CO2,e) and static
extracellular bicarbonate (HCO
{
3,e) concentrations. In our model,
both CO2,e and HCO
{
3,e concentrations are dynamic during
ischemia and reperfusion, as discussed below.
The formulation of the NHE introduced in the CS model
includes allosteric regulation whereby the exchanger is stimulated
by the binding of intracellular protons. There is also the possibility
[22] of additional allosteric regulation whereby the binding of
extracellular protons inhibits the NHE, though whether this is
truly the case is unclear. We have implemented this additional
regulation in our model, as it improves model behavior in terms of
extracellular acidosis that develops during ischemia. Total
allosteric regulation of the NHE is calculated with the following
equation:
regNHE~
½H
z
i  
nNHE,hi
(½H
z
i  
nNHE,hizK
nNHE,hi
NHE )
 !
  1{
½H
z
e  
nNHE,he
(½H
z
e  
nNHE,hezK
nNHE,he
NHE )
 ! ð1Þ
The Hill coefficient for allosteric regulation by extracellular
protons, nNHE,hi, was reported to be about 1, which is the value
that we use. Introducing extracellular allosteric increases the
minimum extracellular pH during ischemia, resulting in a better fit
to the data shown in Figure 4B, but also results in a worse fit to
what is seen in terms of intracellular sodium concentration during
ischemia. As depicted in Figure 4C, intracellular sodium
accumulates during ischemia, and in late ischemia the rate of
sodium accumulation may decrease. Introduction of extracellular
allosteric NHE regulation creates a situation in which intracellular
sodium concentration starts to decrease in late ischemia,
approaching the pre-ischemia value. Increasing the value of
nNHE,he raises the minimum extracellular pH that is reached after
20 minutes of simulated ischemia, but also further decreases the
intracellular sodium concentration. Therefore, we have chosen a
value for nNHE,he that is near what was reported experimentally,
allows for intracellular sodium overload during ischemia, and
results in a degree of extracellular acidosis that is relatively close to
what has been observed experimentally. It should be noted that
here we use the same value for the binding constant of protons,
KNHE, for both intracellular and extracellular regulation. The
value used here is the same as that used in the CS model, and near
what can be extracted for intracellular allosteric regulation from
the data in [23]. When we extracted the binding constant for
extracellular regulation from the same data and used this value for
extracellular regulation, we saw a much worse fit in terms of the
intracellular sodium profile.
As mentioned above, intracellular sodium accumulation falls off
during late ischemia, and in a previous version of the model,
sodium levels would approach or fall below pre-ischemic values.
This is largely due to inhibition of the sodium-calcium exchanger,
which is the primary mover of sodium into the cell. The sodium-
potassium exchanger, which removes sodium, is also strongly
inhibited during late ischemia, but there is still a net loss of sodium.
In order to improve upon this, creating the sustained elevation of
sodium above pre-ischemic levels throughout ischemia that is
observed experimentally, we modified the pH dependence of the
sodium-calcium exchanger. Specifically, the binding constant and
Hill coefficient for proton binding to the sodium-calcium
exchanger were changed to 7.0 and 0.75, respectively, from their
published values of 7.37 and 0.99 [8].
The model, as originally implemented, exhibited high concen-
trations of intracellular sodium at steady state under pre-ischemic
conditions. In addition, the relationship between steady state
sodium concentration and pacing frequency was steeper than both
experimental measurements and simulated experiments using the
LRd model. In order to bring sodium homeostasis in our model in
line with the LRd and closer to what has been seen experimen-
tally, we decreased the scaling factor for the sodium-calcium
exchanger, c1, by 40 percent from the value published in [8]. The
current sodium-pacing frequency relationship is provided in
Figure S4 in Text S1. Decreasing baseline sodium-calcium
exchange flux reduces steady state sodium load, but also increases
intracellular calcium. In order to compensate for this, it was
Ischemia-Reperfusion Modeling and NHE Inhibition
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from 1.15 [8] to 1.65 uA/uF.
In order to simulate the effects and proximal causes of
extracellular potassium (Kz
o ) accumulation during ischemia, we
implemented components that were introduced in a model that
extended the LRd model with the addition and/or modification of
components to study extracellular potassium accumulation during
ischemia [6]. We will henceforth refer to this model as the
Terkildsen-Crampin-Smith (TCS) model. Note that the TCS
model is not an extension of the CS model, as it does not include a
pH regulation system (i.e. equilibration with carbon dioxide,
bicarbonate and intrinsic buffering), acid transporters, or the
inhibitory effects of acidosis on various components of the calcium
handling system. Among other additions, our new model
incorporates all CS and TCS components, save for those relating
to simulating the development of tension in the CS model. The
TCS additions (Figure 2 (red)) allow the sodium-potassium
exchange pump to behave in a more realistic fashion, as it is
sensitive to changes in the concentration of sodium and potassium
on both sides of the plasma membrane, as well as phosphome-
tabolites and pHi. The TCS model also incorporates IK(ATP) and
dynamic intra- and extracellular volumes coupled to water flux.
These potassium-relevant processes have been incorporated into
our model, with changes.
First, we have modified the function for calculating the amount
of water flux to include concentrations of intracellular and
extracellular chloride ([Cl
{
i ] and [Cl
{
e ], respectively):
VH2O~10 Lp R temp ((½Na
z
i   z ½K
z
i   z ½Ca
2z
i   z ½Cl
{
i   z
½X
zi{
i  
Volmyo
)
{(½Na
z
o  z½K
z
o  z½Ca
2z
o  z½Cl
{
e  z
½X
zi{
e  
Volexternal
))
ð2Þ
where Lp is the hydraulic conductivity of the membrane, R is the
universal gas constant, temp is the temperature, [Naz
i ], [Kz
i ],
[Ca2z
i ], [Cl
{
i ] are the intracellular concentrations of sodium,
Figure 2. Mathematical model schematic. The model is an LRd model (black), with additions and modifications that were implemented from the
CS (green) [8] and TCS [6] models (red), as well as an improved SERCA pump from [13] (purple), late sodium current from [27] (grey), the
implementation of ATP-modified L-type calcium channel availability from [26] (orange), and novel additions by the authors (blue). Shaded
components represent those that are regulated by pH and/or phosphometabolites. The model includes systems of equations that regulate
concentrations of ATP, ADP, AMP, inorganic phosphate, creatine, and phosphocreatine, as well as impermeant metabolites that affect water flux.
Abbreviations: Anion: generic anion species produced during ischemia; NCX, sodium-calcium exchanger; NHE, sodium-hydrogen exchanger; NBC,
sodium-bicarbonate symporter; CHE, chloride-hydroxide exchanger; AE, anion exchanger; CMDN, calmodulin; TRPN, troponin C; CSQN, calsequestrin;
JSR, junctional sarcoplasmic reticulum; NSR, network sarcoplasmic reticulum.
doi:10.1371/journal.pcbi.1002241.g002
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o ], [Kz
o ],
[Ca2z
o ], [Cl
{
e ] are the extracellular concentrations of sodium,
potassium, calcium and chloride, respectively, [Xzi{
i ] and [Xzi{
e ]
are the concentrations of non-permeable osmolytes in the
intra- and extracellular compartments, respectively, and Volmyo
and Volexternal are the volumes of the myoplasm and extracellular
compartment, respectively. [Cl
{
e ] is used when initializing [Xzi{
e ],
and [Cl
{
i ] is used when initializing and updating [Xzi{
i ]. Second,
Figure 3. Representative action potentials from the control simulation (no NHE inhibition). In (A), the last action potential prior to the
onset of ischemia (black), at the end of ischemia (gray), and after ten minutes of reperfusion (red) are shown. Panel (B) shows four responses to
stimulation during late ischemia, approximately half a minute before the onset of reperfusion. The resting membrane potential is highly depolarized,
and only every other stimulus generates an action potential.
doi:10.1371/journal.pcbi.1002241.g003
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modified to match a slightly different value for pHi at the
transition from simulated pre-ischemia to ischemia. During
ischemia:
pHi~6:18507{0:56697e{0:19015tz1:5377e{0:18462t ð3Þ
where t is the ischemic time in minutes. It should be noted that the
first term of the pHi ischemia equation may need to be modified if
the model is used with different initial conditions.
As the dynamic nature of extracellular acid status is believed to
play a prominent role in reperfusion arrhythmogenesis, it is highly
desirable to employ a mathematical model that includes a dynamic
extracellular pH system that is as realistic as possible. To this end,
we have made several significant improvements to the represen-
tation of extracellular pH over preexisting models (Figure 2 (blue)).
First, we have introduced intrinsic buffering in the extracellular
compartment. Second, as mentioned previously, [HCO
{
3,e]i s
dynamic during ischemia and reperfusion. Third, flux through
NHE and CHE affects not only pHi, but also pHe. Thus, pHe
during simulated ischemia is influenced by a combination of
equilibration with dynamic CO2,e and HCO
{
3,e concentrations, as
well as an intrinsic buffering system, and flux of protons and
hydroxide ions across the plasma membrane. The change in
extracellular pH at each time step is:
dpHe
dt
~{
1
be
VNHE{VCHEzVhyd,e
Volexternal
  
, ð4Þ
where
be~log10 10{pHez
½ib1  10(pK1{pHe)
(1z10(pK1{pHe))
2 z
½ib2  10(pK2{pHe)
(1z10(pK2{pHe))
2
  
ð5Þ
is the intrinsic buffering power in the extracellular compartment
and
Vhyd,e~Volexternal(k
z
hyd½CO2,e {k
{
hyd½HCO
{
3,e ½Hz
e  ) ð6Þ
represents equilibration between protons, bicarbonate and carbon
dioxide in the extracellular compartment. Eqs. 4–6 are nearly the
same as their intracellular counterparts, as provided in [8] save for
the reversal of signs for VNHE and VCHE and the substitution of
extracellular for intracellular species concentrations and volumes.
Concentrations and pK values of the intrinsic buffers are the same
as in the intracellular compartment. Equations for VNHE and
VCHE are provided in Text S1 and [8].
Because the concentrations of protons are explicitly represented
in our model, and because part of the ischemia simulation protocol
is to impose a progressive intracellular acidosis on the system
during ischemia, it is necessary to account for conjugate anions
that are produced as the metabolic acidosis progresses in order to
maintain charge conservation. This is accomplished by the
introduction of a variable representing the concentration of
generic monovalent anions produced in a 1:1 stoichiometry with
the surplus protons that appear as pHi decreases.
½Anion{ ~(103{pHi{½Protonref )z(½Hib1 z½Hib2 {½Hibref ), ð7Þ
where
½Hib1 ~
½ib1  10{pHi
10{pHiz10{pK1 ð8Þ
and
½Hib2 ~
½ib2  10{pHi
10{pHiz10{pK2 ð9Þ
are the concentrations of protons bound to the two generic
intrinsic buffers, ib1 and ib2, and
½Protonref ~103{pHi ð10Þ
and
½Hibref ~
½ib1  10{pHi
10{pHiz10{pK1 z
½ib2  10{pHi
10{pHiz10{pK2 ð11Þ
are the concentrations of free intracellular protons and protons
bound to the intrinsic buffers, respectively, at the beginning of a
simulation, such that [Anion{] is initially equal to zero. Eqs. 8
and 9 are from [8].
Experiments have shown that the availability of L-type calcium
channels (ICa(L)) is modified by the concentration of ATP [24,25].
Accordingly, we have included a term to represent this change in
channel availability (Figure 2 (orange)) [26]:
fCa,ATP~
1
1z
kATP
½ATP 
   2:6 , ð12Þ
where [ATP] is the concentration of ATP and kATP is the k1=2 for
the binding of ATP to ICa(L) channels.
Finally, we implemented a newer version, relative to that used in
the CS model, of the SERCA pump (Figure 2 (purple)) from [13].
The cycling rate of SERCA, cycSERCA, (see Text S1 or [13]) is
translated to calcium flux via the following equation:
VSERCA~0:00820cycSERCA ð13Þ
The conversion factor of 0.00820 was derived by first implement-
ing SERCA such that it was unidirectionally coupled (i.e. could
respond to changes in pHi,[ Ca2z
i ], [ATP], etc., but could not
affect the remainder of the system) and simulating normal pre-
Figure 4. Comparison of mathematical model behavior to experimental data. Changes in (A) intracellular pH (pHi), (B) extracellular pH
(pHe), and (C) intracellular sodium (Naz
i ) concentration during experimental (circles) and simulated (lines) ischemia (gray region) and reperfusion. For
(A), the dashed line denotes the part of the simulation in which pHi was prescribed by the ischemia-reperfusion protocol (Eq. 3). The solid line
represents the part of the simulation in which pHi evolved according to the model equations (Eq. 29). Data points and error bars were extracted from
[30] using the DigitizeIt software (share-it!, Denmark). For (B), the dashed line denotes the part of the simulation in which pHe was prescribed by the
ischemia-reperfusion protocol (Eq. 28). The solid line represents the part of the simulation in which pHe evolved according to the model equations
(Eq. 4). Data points and error bars were extracted from [32] using the DigitizeIt software (share-it!, Denmark). For (C), data points and error bars were
extracted from [33] using the DigitizeIt software (share-it!, Denmark).
doi:10.1371/journal.pcbi.1002241.g004
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cycSERCA were recorded at the peak of the intracellular calcium
transient at pre-ischemic pHi. These values were used in our
model to scale the raw cycSERCA value to produce VSERCA output
that results in appropriate Ca2z
i transients.
Ischemia and Reperfusion Simulation Protocols
Throughout all simulations, the cell was constantly stimulated
at a rate of 3 Hz using pulses of 280.0 uA/uF and lasting
0.5 ms. Starting from the initial conditions provided in Table 1,
the cell was paced for five minutes of simulated time, well past the
required time for the model to reach steady state, before the onset
of simulated ischemia. During pre-ischemia, the concentrations
of all extracellular species are held constant, the assumption
being that the extracellular compartment has access to, and is in
equilibrium with, a pool that is many orders of magnitude larger
than the volume of the immediate extracellular space. pHi,o n
the other hand, is dynamic and is updated per Eq. 29 below,
although it fluctuates very little under these conditions.
In this study we have simulated an abrupt-onset total ischemia.
During ischemia, as oxygen availability falls and the cell switches
to anaerobic metabolism, metabolic acidosis develops. The
metabolic byproducts responsible for this acidosis are not
represented in our model, and so we impose metabolic acidosis
on the intracellular compartment via Eq. 3. Also, during
ischemia the extracellular compartment becomes more acidic
due to flux through the acid exchangers and the accumulation of
carbon dioxide. In our model the extracellular compartment is
considered to be completely isolated, such that gases and ions
accumulate or deplete via flux through ion channels and trans-
porters. While we must impose pH changes on the intracellular
compartment during simulated ischemia, pH changes in the
extracellular compartment are allowed to respond to acid
exchanger flux and carbon dioxide accumulation, and are
calculated per Eq. 4. Accumulation of carbon dioxide in the
extracellular space is modeled by:
d½CO2,e 
dt
~{
VCO2zVhyd,e
Volexternal
ð14Þ
where VCO2 is transport of CO2 across the plasma membrane
and Vhyd,e represents the concentration of CO2,e produced or
consumed from equilibration with HCO
{
3,e in the extracellular
compartment (Eq. S.167 in Text S1).
[HCO
{
3,e], [Naz
o ], [Kz
o ], and [Ca2z
o ], which are no longer
fixed as these species are accumulating or being depleted from the
extracellular compartment while it is isolated during simulated
ischemia, are updated per the following equations:
d½HCO
{
3,e 
dt
~
Vhyd,e{VNBCzVAE
Volexternal
, ð15Þ
d½Naz
o  
dt
~
INa,total   Cm   Acap
F   zNa   Volexternal
{
VNHEzVNBC
Volexternal
, ð16Þ
d½Kz
o  
dt
~
IK,total   Cm   Acap
F   zK   Volexternal
, ð17Þ
and
Table 1. Initial conditions.
Parameter Value
V 277.00
pHi 7.15
pHe 7.40
½Hz
i   0.000070795
½Hz
e   0.000039811
½OH{
i   0.000141254
½OH{
e   0.000251189
½Naz
i   14.34
½Naz
o   149.02
½Kz
i   109.10
½K
z
o   5.40
½Cl
{
i   33.77
½Cl
{
e   146.7
½Ca2z
i   0.000335
½Ca2z
o   1.80
½JSR  0.605236
½NSR  2.352399
m 0.005751
h 0.894526
j 0.889565
d 0.000022
f 0.990176
fca 0.640341515
xs1 0.059092
xs2 0.108548
xr 0.005171
b 0.002925
g 0.899522
p 0.018649
½CO2,i  0.741684
½CO2,e  0.741684
½HCO
{
3,i  7.90
½HCO
{
3,e  11.90
½ATP  7.216
½ADP  0.036
½AMP  0.000184
½Pifree  0.8
½PCr  13.3
½Cr  8.9
Pi 310.0
Pe 310.0
Volcell 0.00003801
Volmyo 0.000025847
Volsr 0.000002281
Volnsr 0.000002098
Voljsr 0.000000182
Volexternal 0.000005172
½X
zi{
i   0.00393598
½X
zi{
e   0.000036618
doi:10.1371/journal.pcbi.1002241.t001
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o  
dt
~
ICa,total   Cm   Acap
F   zCa   Volexternal
, ð18Þ
where INa,total, IK,total, and ICa,total represent the total current
through relevant ion channels, the NaK exchanger and NCX
exchanger for Naz, Kz, and Ca2z, respectively. Eqs. 15–18 are
derived from the equations for updating intracellular species
concentrations in [8].
During ischemia, sodium channel conductance, gNa,i s
decreased from 16.0 to 14.4 mS/uF. In addition, late sodium
current, defined by [27]:
INa,l~modifierInal   gNa   p3   (V{ENa) ð19Þ
is increased by increasing the value of modifierInal from 0.0007 to
0.00018.
Ischemia results in decreased availability of ATP and phospho-
creatine. We impose decreasing concentrations of ATP and PCr
on the system during simulated ischemia, which then affect
concentrations of the other phosphometabolites, per the following
equations, from [6]:
½ATP ~0:0006549t3{0:02305t2{0:104837tz7:216, ð20Þ
½PCr ~{0:01259z12:339e{0:92559tz0:96819e{0:078496t, ð21Þ
½Cr ~22:2{½PCr , ð22Þ
½ADP ~
½ATP  ½ Cr 
½PCr  ½ Hz
i  1:66x106 , ð23Þ
½AMP ~
½ADP  ½ ADP  1:05
½ATP 
, ð24Þ
and
½Pifree ~½Pitotal{(3  ½ ATP z2  ½ ATP z½AMP z½PCr ), ð25Þ
where t is the ischemic time in minutes and [Hz
i ]=1000*10{pHi.
Note that Eq. 20 has been modified from [6].
Finally, as described in [6], a variable representing intracellular
osmolarity is linearly increased during ischemia:
P
i
~310zt, ð26Þ
where t is the ischemic time in minutes. Pi is subsequently used to
update [Xzi{
i ] at each time step:
½Xzi{
i  ~Volmyo(P
i
{½Naz
i  {½Kz
i  {½Ca2z
i  {½Cl
{
i  ) ð27Þ
for use in calculating water flux (see Text S1).
As discussed above, it is believed that acidic extracellular fluid is
washed out during reperfusion and replaced with fluid from
elsewhere that is at normal pH, carrying away accumulated
protons and carbon dioxide. Also, oxygen concentration increases,
reducing the cell’s dependence on anaerobic metabolism and
abolishing the source of metabolic acidosis. Therefore, as opposed
to simulated ischemia, during which pHi is prescribed and pHe
evolves according to Eq. 4, during simulated reperfusion pHe is
prescribed according to Eq. 28 in order to simulate washout and
pHi is allowed to evolve according to Eq. 29 below. pHe is
prescribed according to the following formula:
pHe,t~pHe,t{Dtz
(7:40{pHe,t{Dt)
1:5|105ms
Dt, ð28Þ
where 7.40 is the pre-ischemic pHe and Dt is the length of the time
step. When using a time step of 0.005 ms, the time constant of
1.56105 ms produces a recovery to pre-ischemic pHe in about
10 minutes. We have attempted to choose a recovery rate that is
consistent with what has been observed experimentally, but data
regarding the pHe recovery profile during reperfusion is scarce. In
one porcine experiment [28], pre-ischemic pHe was reached after
about 10 minutes, following 10 minutes of ischemia. In another
experiment performed on canines, recovery took 20–30 minutes
following 90 minutes of ischemia [29]. We have chosen a recovery
time of approximately 10 minutes because it produces a better fit
to experimental data for other parameters, such as pHi and
[Naz
i ].
The change in pHi at each time step is calculated according to
the following formula:
dpHi
dt
~{
1
bi
{VNHEzVCHE
Volmyo
z
Vhyd,i
VolmyozVolsr
  
, ð29Þ
where
bi~log10 10{pHiz
½ib1  10(pK1{pHi)
(1z10(pK1{pHi))
2z
½ib2  10(pK2{pHi)
(1z10(pK2{pHi))
2
  
ð30Þ
is the intrinsic buffering power in the intracellular compartment,
VNHE and VCHE represent flux through the NHE and CHE,
respectively, Volmyo and Volsr represent the volumes of the
myoplasm and sarcoplasmic reticulum, respectively, and
Vhyd,i~Volmyo(k
z
hyd½CO2,i {k
{
hyd½HCO
{
3,i ½Hz
i  ) ð31Þ
represents equilibration between protons, bicarbonate and carbon
dioxide in the intracellular compartment. Eqs. 29–31 are from [8].
Equations for VNHE and VCHE are provided in Text S1 and [8].
It is assumed that other extracellular species (Naz
o , Kz
o , Ca2z
o ,
Cl
{
e , HCO
{
3,e, and CO2,e) will return to their normal concentra-
tions during reperfusion, now that they are again in equilibrium
with a vastly larger pool. We have chosen a time constant of
3.756104 ms, such that the concentration of a particular ion or
molecule is updated according to the following equation:
½ion t~½ion t{Dt{
½ion t{Dt{½ionpreischemic 
3:75|104ms
Dt: ð32Þ
This produces a recovery to preischemic concentrations in
approximately two minutes, consistent with what has been
observed during reperfusion in Langendorff-perfused tissue [5].
The idea here is to simulate the wash out (or wash in, as the case
may be) of extracellular species as the fluid in the previously
Ischemia-Reperfusion Modeling and NHE Inhibition
PLoS Computational Biology | www.ploscompbiol.org 9 October 2011 | Volume 7 | Issue 10 | e1002241isolated extracellular compartment is replaced with fluid replen-
ished by blood arriving from outside the ischemic region.
Based upon experimental evidence, it appears that ATP and
PCr can recover to as much as 40 and 75 percent of their
preischemic concentrations following ischemia in Langendorff-
perfused guinea pig hearts [30]. It also appears that most recovery
happens within the first few minutes of reperfusion. Therefore,
[ATP] and [PCr] are calculated according to the following
equations during simulated ischemia:
½ATP t~½ATP t{Dt{
½ATP t{Dt{0:4½ATPpreischemic 
1|104ms
Dt ð33Þ
½PCr t~½PCr t{Dt{
½PCr t{Dt{0:75½ionpreischemic 
1|104ms
Dt: ð34Þ
The concentrations of all other phosphometabolites are calculated
as they were during ischemia.
Finally, intracellular osmolarity is returned to normal according
to the following equation:
P
i,t
~ P
i,t{D1
{
Pi,t{Dt {310
3:75|104ms
Dt: ð35Þ
NHE Inhibition
Flux through the NHE is computed using the following
equation:
VNHE~modifierNHE   Volmyo   regNHE
 
k
{
NHE1   s6NHE{k
z
NHE1   s1NHE
60,000
ð36Þ
(see Text S1 for preceding equations). In order to simulate the
effects of agents that inhibit the NHE, we reduced the value of
modifierNHE from its default value of 1.0 to one of two values:
0.50 or 0.0. In addition, we introduced each of these degrees of
NHE inhibition at one of three time points: the end of 20 minutes
of ischemia (denoted reperfusion in figures), after 10 minutes of
ischemia (denoted mid-ischemia in figures), or at the onset of
ischemia (denoted ischemia in figures).
Differential equations were solved using the forward Euler
method. Model code is available as a supplemental download.
Results
Membrane Voltage
Figure 3A illustrates action potentials before (black) and at the
end (gray) of ischemia, as well as following 10 minutes of
reperfusion (red), from the control simulation. Note that after
ten minutes of reperfusion, the action potential duration and
amplitude are still smaller than before the onset of ischemia,
consistent with what has been observed in guinea pig experiments
[31]. Figure 3B illustrates responses to four stimulus events during
late ischemia. Note that the resting membrane potential is
depolarized to a degree similar to that which has been observed
in guinea pig experiments [5]. Also, cell excitability is extremely
impaired, with only every other stimulus eliciting an action
potential.
pH and Ion Concentrations
Figure 4 provides a comparison of experimental data to results
obtained when we simulated 20 minutes of ischemia (grey shading)
followed by 10 minutes of reperfusion. The simulation results in all
panels of Figure 4 (solid lines) are from the control simulation, in
which no NHE inhibition was instituted. Comparing simulation
results to experimental data from [30] in Figure 4A, it can be seen
that our model closely reproduces the behavior of intracellular pH
observed in guinea pig myocytes during ischemia and reperfusion.
As discussed above, pHi during simulated ischemia evolves
according to a fixed equation (Eq. 3) implemented to reproduce
what occurs experimentally. However, pHi during reperfusion,
which is calculated by Eq. 29, is not pre-determined.
In Figure 4B, results from the same control simulation are
compared to experimentally measured pHe during 20 minutes of
guinea pig ischemia [32]. Our model and simulation protocol
produce a pHe profile that closely reproduces what is observed
during early ischemia, but continues with a steep decline for a
longer period of time, producing an extracellular pH after
20 minutes of ischemia that is about 0.2 units lower than what
was seen in the guinea pig heart.
Figure 4C compares results from the same control simulation to
[Naz
i ] measured in guinea pig hearts during ischemia and
reperfusion [33]. In both cases, there is an accumulation of sodium
inside the cell during ischemia, although our model shows a more
modest increase. This is largely due to the higher starting
concentration, which is determined from a steady state value that
is heavily dependent upon NaK pump density and the amount of
allosteric regulation by extracellular protons at the NHE. Also,
both the experimental and simulated results show a second, more
profound, sodium overload upon reperfusion. It should be noted
that in the experiment cited here, reperfusion was preceded by
30 minutes of ischemia, not 20, as is the case with the other
experimental comparisons.
Figure 5 shows intracellular sodium, calcium, and pH profiles
from a subset of simulations. The black lines representing the
control simulations in this and subsequent figures are the same as
shown in Figure 4. In addition to the control simulation, results
from the following three simulations are shown: either a 50 or 100
percent reduction in NHE flux beginning at the onset of
reperfusion, and a 100 percent reduction at the onset of ischemia
(denoted as R50, R0, and I0 in tables). In Figure 5A, the
intracellular sodium concentration throughout each of the four
aforementioned simulations can be seen. Table 2 provides peak
and mean intracellular sodium concentrations during reperfusion,
the concentration of sodium at the end of ischemia, and ratios of
peak to end-ischemic sodium concentrations for all simulations.
Peak and end-ischemia sodium concentrations for all simulations
are shown in Figures 6A and 6B, respectively. One obvious feature
of Figures 5A and 6A is that there is minimal, if any, benefit in
terms of peak sodium concentration during reperfusion, regardless
of when and how much NHE inhibition is imposed. In fact, when
NHE inhibition is instituted at reperfusion, there is a worsening of
peak sodium concentration during reperfusion relative to control
(green and blue lines). In simulations where NHE inhibition was
started at earlier time points, there is a reduction in [Naz
i ] prior to
the onset of reperfusion. However, this appears to have a relatively
small impact on the concentrations of sodium at the end of the
observed reperfusion period.
Figure 5B plots the maximum and minimum myoplasmic
calcium concentrations for each beat in the same four simulations.
The three insets show calcium transients, plotted on the same
vertical axis as panel B, for 2000 ms in the regions marked
by dashed vertical lines. Table 3 provides peak and mean
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well as ratios, as in Table 2. Peak Ca2z
i concentrations for all
simulations are graphed in Figure 6C. The largest calcium
concentrations were seen during the R0 (complete NHE block
starting at reperfusion) simulation, as was also the case for sodium
(Figure 6A and Table 2).
Intracellular pH profiles for the same four simulations are
shown in Figure 5C. The values of intracellular pH after
10 minutes of reperfusion (graphed in Figure 6D), as well as the
mean pHi during reperfusion, are provided in Table 4. Relative to
the control simulation, 10-minute and mean pHi values are lower
regardless of when and how much NHE inhibition was imposed.
The lowest pH values were observed during the R0 simulation,
which is also the simulation in which the most severe sodium and
calcium overloads were observed.
Sodium Flux
In our model, there are eight components through which
sodium can enter and/or leave the cell: the sodium-hydrogen
exchanger (NHE) and sodium-bicarbonate symporter (NBC), two
of the so-called acid exchangers, the sodium-calcium exchanger
(NCX), sodium-potassium exchanger (NaK), fast-sodium current
(INa), background sodium current (INa,b), late sodium current
(INa,l), and sodium movement through the L-type calcium channel
(ICa(L),Na). In order to develop an understanding of the relative
importance of each of these eight sodium flux pathways to sodium
overload, we analyzed current through each of these during the
ten minutes of simulated reperfusion. Table 5 and Figure 7
provide the net number of moles of sodium moved through each
component during the ten minutes of reperfusion. This value was
calculated as per Eq. 37 for NHE and NBC and Eq. 38 for the
remaining six ion channels and exchangers:
Ionstotal~Dt
X
Vexchanger ð37Þ
Ionstotal~Dt
Cm   Acap
F
X
Ichannel, ð38Þ
where Dt is the time step, Acap is the capacitive area, and F is
Faraday’s constant, as provided in Text S1. Vexchanger is the flux
through either the NHE or NBC at a given time step, and Ichannel
is the current through one of the six ion channels or exchangers at
a given time step. For the NCX and NaK, the value calculated by
Eq. 38 is multiplied by 3. Note that this is not the true number of
moles of ions moved. Mathematical simulations are discretized
into finite time steps, and data was not written at every time step in
order to keep data file sizes within manageable limits. Nonetheless,
these values provide a standard with which the contributions of
each of the eight sodium components can be compared across
different simulations. In these simulations, data was sampled every
tenth time step. The only sodium pathway which has a net
negative inward sodium movement is the NaK. The NCX, which
functions in both forward (sodium in) and reverse (sodium out)
modes, increasingly favors the reverse mode during sodium
overload,
We also calculated the proportion of total moles of sodium
moved for each of the eight sodium pathways, presented in
Table 6. The proportion values were calculated by taking the
absolute value of the total ion movement for a given component
and simulation, and dividing by the sum of the absolute values for
all eight components in the same simulation. As can be seen in
Table 6, the NaK and NCX are responsible for most of the
sodium movement into and out of the cell.
As additional model validation, we performed additional
simulations and compared the results to an analysis of sodium
fluxes in rabbit myocytes [34]. The model was allowed to reach
steady state either when paced at a rate of 1 Hz under pre-
ischemic conditions, left at rest under pre-ischemic conditions, or
left at rest in mild acidosis (pHi set to 6.9). Sodium flux through all
seven components that produce net inward sodium movement
were analyzed for the last minute of simulated time (please see
Figure S1 in Text S1 for results). As expected, and consistent with
data summarized in [34], there was less sodium influx when the
cell was at rest than when paced, due to reduced current through
the sodium channels and NCX. However, also as expected and
consistent with experimental observations, there was more sodium
influx at rest when the cell was experiencing mild acidosis than
when the resting cell was at normal pH. This was due, at least in
part, to increased flux through NHE and NBC. During acidosis
there was decreased NCX flux in both the simulated and
experimental preparations, but this is not surprising as the NCX
experiences inhibition at lower pH.
The Sodium-Potassium Exchanger and Acidosis
Given that the NaK is one of the dominant sodium flux sources
and that it is inhibited by low pHi, we wanted to examine the
effects of removing this acidotic inhibition during reperfusion. For
this simulation, our model was modified such that a separate
variable for intracellular pH was created and incorporated into the
equations for calculating NaK flux. During the pre-ischemic and
ischemic phases of the simulation, this variable equals the value of
the general pHi variable. However, during reperfusion, the value
of this NaK-specific pH variable is returned to normal, while the
rest of the model responds to the values of pHi such as those in
Figure 5C.
Figure 5. Changes in ion concentrations and pH during simulated reperfusion. (A) intracellular sodium (Naz
i ), (B) maximum and minimum
intracellular calcium (Ca2z
i ), and (C) intracellular pH (pHi) during simulated ischemia (gray region) and reperfusion during four simulations: Control
(with no NHE inhibition) (black), NHE inhibition beginning with reperfusion at 50 percent (blue) or 100 percent (green) reduction, and 100 percent
NHE blockade beginning with ischemia (light blue). In (B), the three insets, plotted on the same vertical axis as the main figure, show 2000 ms of
intracellular calcium transients corresponding to the regions denoted by the vertical dashed lines: just prior to the onset of ischemia (left); during late
ischemia, demonstrating alternans (middle); and late in the observed reperfusion window (right).
doi:10.1371/journal.pcbi.1002241.g005
Table 2. Intracellular sodium.
Control R50 R0 M50 M0 I50 I0
Peak [Naz
i ] 19.50 19.71 20.21 19.52 19.34 19.51 19.34
Mean [Naz
i ] 17.48 17.47 17.46 17.24 16.58 17.23 16.47
End-ischemic [Naz
i ] 12.63 12.63 12.63 12.11 10.24 12.09 9.85
Peak/End [Naz
i ] Ratio 1.54 1.56 1.60 1.61 1.89 1.61 1.96
Normalized Ratio 1.00 1.01 1.04 1.04 1.22 1.05 1.27
Concentrations in mM.
doi:10.1371/journal.pcbi.1002241.t002
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variable. The effects on sodium and calcium concentrations can be
seen in Figures 8A and 8B, respectively. Removing acidosis-
induced NaK inhibition reduced the peak [Naz
i ] over 2 mM to
just under 18 mM and the peak [Ca2z
i ] was reduced to
0.00125 mM.
Figure 8C compares the maximum and minimum values of
INaK during each beat from the control and R0 simulations to the
modified R0 simulation with acidotic inhibition removed. The two
insets capture 150 ms, plotted on the same vertical axis as the
main figure, at the end of pre-ischemia (left) and at the end of
reperfusion (right). If the NaK is not impaired by acidosis during
reperfusion, it experiences greater minimum current. Maximum
current is still suppressed during early reperfusion, but improves
during middle to late reperfusion.
Discussion
We have developed a model that is capable of simulating the
key initial events of myocardial reperfusion: the washout of
acidotic and hyperkalemic extracellular fluid, restoring a proton
gradient leading to intracellular sodium and calcium overload. A
previous model [8] was able to simulate the creation of a proton
gradient upon reperfusion, leading to sodium and calcium
overload, but that model was developed to simulate respiratory
acidosis, not ischemia. As such, the intra- and extracellular pH
regulation systems were not fully coupled (i.e. flux of protons and
hydroxide through the acid exchangers did not have any effect on
the extracellular pH). In addition, our new model incorporates pH
sensitivity of the NaK, which was not included in the CS model.
Given the important role that phosphometabolites such as ATP
Table 3. Intracellular calcium.
Control R50 R0 M50 M0 I50 I0
Peak [Ca2z
i ] 0.001702 0.001725 0.001772 0.001705 0.001689 0.001704 0.001689
Mean [Ca2z
i ] 0.000738 0.000751 0.000780 0.000738 0.000729 0.000739 0.000730
End-ischemic [Ca2z
i ] 0.000400 0.000400 0.000400 0.000394 0.000412 0.000471 0.000451
Peak/End [Ca2z
i ] Ratio 4.26 4.31 4.43 4.33 4.10 3.62 3.75
Normalized Ratio 1.00 1.01 1.04 1.02 0.96 0.85 0.88
Concentrations in mM.
doi:10.1371/journal.pcbi.1002241.t003
Figure 6. Changes in ion concentrations and pH: peak intracellular sodium during reperfusion (A), end-ischemic intracellular
sodium (B), peak intracellular calcium during reperfusion (C), and intracellular pH after 10 minutes of reperfusion (D). In addition to
the control simulation (no NHE inhibition), simulations were performed in which NHE flux was either reduced by 50 percent or completely blocked
beginning at the onset of reperfusion (blue), half-way through ischemia (red), or at the onset of ischemia (green).
doi:10.1371/journal.pcbi.1002241.g006
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reperfusion events, including the flux of sodium and calcium, we
sought to incorporate the ATP dependence of various cellular
components into our model. Finally, we wanted to represent
dynamic concentrations of as many extracellular species as
possible. In particular, modeling dynamic extracellular potassium
is important, as it affects sodium concentration via the NaK, as
well as the depolarized resting membrane potential that develops
during ischemia.
NHE inhibitors reduce the influx of sodium through the NHE
when a proton gradient is restored upon reperfusion. However,
NHE inhibitors also reduce the efflux of protons through this same
exchanger [4], which is a significant means of proton removal
from cardiac cells [35]. Given the role that sodium overload plays
in the pathophysiology of reperfusion injury, NHE inhibition
would appear to be a viable therapy. NHE inhibitors have had
some success at reducing the incidence of reperfusion arrhythmias
in animal studies [4], as well as reducing the concentration of
intracellular sodium when given prior to the onset of ischemia
[33]. However, as discussed earlier, NHE inhibitors have not
demonstrated any real utility in the clinical setting.
One possible reason for the lack of clinical efficacy is that NHE
inhibition may not in fact produce the desired reductions in
sodium and calcium overloads. Our simulation results indicate
that NHE inhibition, when applied with varying degrees and at
various time points during the ischemia-reperfusion event, has a
relatively minor impact on the development of sodium and
calcium overload during reperfusion. This has been observed
experimentally: in a study of rat myocytes exposed to anoxic
conditions or metabolic inhibition, NHE inhibition failed to
attenuate sodium and calcium overload [36].
In our simulations, the scenarios that produced the lowest peak
and mean sodium concentrations during reperfusion were those
that exhibited the lowest sodium concentrations at the end of
ischemia (Table 2 and Figures 6A and B). NHE inhibition during
or prior to the onset of ischemia reduces the intracellular sodium
load by the time reperfusion occurs, which appears to confer some
benefit in terms of how much sodium accumulates when the
proton gradient is restored. This is consistent with what was
observed in the aforementioned guinea pig ischemia experiment
[33], where inhibiting the NHE prior to and during ischemia
suppressed sodium load during the ischemic phase and attenuated
(although did not abolish) sodium overload upon reperfusion.
However, the amount of sodium overload during reperfusion is
not only dependent upon the concentrations at the end of
ischemia, as can be seen by examining the normalized ratios in
Table 2. These ratios highlight the interesting fact that the peak
sodium concentrations during reperfusion are all similar (within
0.87 mM), despite a wider range of concentrations at the
beginning of reperfusion (2.78 mM).
pH-related dynamics appear to play a significant role in setting
the approximate peak sodium concentration during reperfusion.
While the peak sodium (and calcium) overloads are similar in all
simulations, these overloads are clearly the most severe in the R0
simulation, which also manifested the lowest mean and 10-minute
reperfusion pHi values (Table 4). When complete NHE inhibition
was instituted at earlier time points (M0 and I0 simulations), more
pH recovery was permitted during reperfusion. This appears to be
due to the fact that lower end-ischemia sodium concentrations
favor NHE flux, partially compensating for the imposed NHE
inhibition.
Examining the two simulations in which NHE inhibition began
at reperfusion is helpful, in that prior to the onset of inhibition all
simulations experienced the same history. As NHE inhibition
severity is increased from 50 percent (R50) to 100 percent (R0), the
peak sodium concentrations during reperfusion increased from
19.71 to 20.21 mM (Table 2) and mean pHi decreased from 7.05
to 6.99 (Table 4), suggesting that there is a relationship between
sodium overload and the amount of pH recovery that is permitted.
This relationship is the opposite of what one would expect if
thinking only in terms of the NHE, which should reduce pH
recovery but also reduce sodium overload when inhibited.
Therefore, pH-dependent effects on other subcellular components
must be responsible for the persistent sodium overload. It should
be noted that this relationship does not always hold in the other
simulations where NHE inhibition starts at earlier time points.
This is largely due to the lower end-ischemic values of [Naz
i ]i n
these simulations.
Given the counterintuitive relationship between pH recovery
and sodium overload, the next question we asked was which
subcellular components appear to be responsible? There are 8
Table 4. Intracellular pH.
Control R50 R0 M50 M0 I50 I0
End pHi 7.09 7.05 6.99 7.06 7.02 7.06 7.02
Mean pHi 6.93 6.89 6.80 6.90 6.88 6.90 6.87
doi:10.1371/journal.pcbi.1002241.t004
Table 5. Net number of sodium moles moved (610{9).
Control R50 R0 M50 M0 I50 I0
NHE 1.23E206 8.30E207 0.00E+00 8.19E207 0.00E+00 8.20E207 0.00E+00
NBC 4.14E207 5.40E207 9.19E207 5.25E207 9.06E207 5.24E207 9.45E207
NCX 8.75E206 8.55E206 8.10E206 8.79E206 9.00E206 8.80E206 9.03 E206
NaK 21.40E205 21.35E205 21.24E205 21.36E205 21.30E205 21.36E205 21.29E205
INa 1.93E206 1.92E206 1.91E206 1.91E206 1.87E206 1.91E206 1.86E206
INa,l 1.14E207 1.14E207 1.14E207 1.15E207 1.20E207 1.15E207 1.21E207
INa,b 2.16E206 2.16E206 2.16E206 2.17E206 2.18E206 2.17E206 2.18E206
ICa(L),Na 1.16E206 1.16E206 1.15E206 1.18E206 1.22E206 1.18E206 1.21E206
Total 2.98E205 2.88E205 2.68E205 2.91E205 2.82E205 2.91E205 2.83E205
doi:10.1371/journal.pcbi.1002241.t005
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our model, and their relative contributions in each simulation are
displayed in Figure 7 and Tables 5 and 6. The two biggest
contributors are the NCX and NaK, transporting approximately
29 and 47 percent of the total moles of sodium during reperfusion
(control simulation), respectively. Both of these exchangers are
sensitive to changes in pHi in that they are inhibited by acidosis.
Examination of the mean sodium concentrations during reperfu-
sion in Table 2 and the total number of sodium ions moved in
Table 5 reveals that NCX (which moves more sodium into the cell
than out) is not likely to be responsible for the sodium overloads
observed during reperfusion. During the R-series simulations,
where mean sodium concentration increases as the severity of
NHE inhibition increases, total NCX ion movement decreases.
The opposite is true of the M- and I-series simulations, where
increasing NHE inhibition is associated with decreased sodium
concentration but increased NCX current. The NCX, although it
is inhibited to some degree by acidosis, appears to be largely
responding to changes in sodium concentration. Examination of
the mean pHi values in Table 4 and the number of moles moved
in Table 5 reveals that the two are sometimes directly related, but
at other times the relationship is inverse.
On the other hand, NaK current, as presented in Table 5, is
always directly related to mean pH (Table 4) but not always with
mean sodium concentration (Table 2). Suppression of pH recovery
appears to inhibit NaK activity, thereby reducing the number of
Figure 7. Number of sodium ions moved during each simulated reperfusion by each of eight sodium components: the L-type
calcium channel (ICa(L),Na), rapid sodium current (INa), background sodium current (INa,b), late sodium current (INa,l), sodium-
potassium exchanger (NaK), sodium-calcium exchanger (NCX), sodium-bicarbonate symporter (NBC), and sodium-exchanger
(NHE). In addition to the control simulation (no NHE inhibition), simulations were performed in which NHE flux was either reduced by 50 percent or
completely blocked beginning at the onset of reperfusion (blue), half-way through ischemia (red), or at the onset of ischemia (green).
doi:10.1371/journal.pcbi.1002241.g007
Ischemia-Reperfusion Modeling and NHE Inhibition
PLoS Computational Biology | www.ploscompbiol.org 15 October 2011 | Volume 7 | Issue 10 | e1002241sodium ions removed from the cell during reperfusion. This theory
appears valid if examining the results of the R-series experiments,
but appears to break down when examining the mean and peak
sodium concentrations of the other simulations, where peak and
mean sodium overload decrease and pH recovery decreases.
However, in these simulations there are also progressively
decreasing end-ischemic sodium concentrations. If one considers
the amount of sodium that enters the cell during reperfusion in
relation to what was present at the end of ischemia (as represented
by the ratios in Table 2), suppressed pHi, and NaK current
correlate with sodium overload. When we removed the effects of
pH-dependent inhibition upon the NaK during reperfusion, we
observed significant improvements in terms of sodium and calcium
overload (Figures 8A and 8B, respectively) that appear to be
mediated by increased NaK current (Figure 8C).
It is interesting to compare these findings with those from
another modeling study in which acid-loading was employed as an
analog to ischemia-reperfusion [18]. As in our study, Ch’en et al,
found that NHE inhibition impaired intracellular pH recovery.
However, sodium overload following the acid load was reduced,
not increased, as was the case with our NHE inhibition
simulations. This fundamentally different behavior is largely the
result of adding pH dependence to the NaK, which appears to be
absent in the older model.
The only other sodium flux source that appeared to play a role
in sodium overload during reperfusion was the NBC, which moves
sodium, as well as bicarbonate, into the cell. We observed that as
the strength of NHE inhibition was increased, which suppresses
pH recovery, intracellular bicarbonate concentrations were
decreased (Table 7) and NBC flux increased (Table 5). Keeping
intracellular pH low would be expected to produce lower
bicarbonate concentrations, leading to a gradient that favors
NBC import of bicarbonate, and sodium along with it.
Given the apparent failure of NHE inhibition to attenuate
sodium overload during reperfusion, and the prominent role that
NaK plays in intracellular sodium regulation, we investigated
whether the NaK could be manipulated in order to improve
sodium overload. To this end, we performed two additional
simulations, the results of which are provided in Figure S2 in Text
S1. In the first, we doubled the amount of NaK current starting at
the moment of initial reperfusion. This produced a dramatic
reduction in overload during reperfusion, with a peak concentra-
tion of about 12 mM. However, there is no known way to directly
increase NaK activity in such a selective fashion. NaK activity can
likely be stimulated indirectly by making more ATP available. In
the second simulation, we allowed ATP concentration to recover
to the preischemic value during reperfusion, as opposed to limiting
recovery to 40 percent of the preischemic value. This approach
also produced a dramatic reduction in sodium overload, resulting
in a peak concentration similar to that observed in the first
simulation. Delivery of ATP encapsulated in liposomes [37] has
been shown to reduce the extent of ischemia-reperfusion injury in
vitro and in vivo. Whether such improvement was the result of
increased NaK activity remains to be shown, but the prospect
appears promising nonetheless.
NHE inhibition and the resulting suppression of pH recovery
during reperfusion appears to worsen sodium load, and in
simulations where we removed pH-related inhibition of the NaK,
there was a reduction in sodium load relative to control (Figure 8A).
However, there was still a substantial overload during reperfusion
(gray line). This, combined with the results of simulations discussed
in the preceding paragraph and Figure S2 in Text S1, suggest
anotherpossiblereasonwhyNHEinhibitionhasthus farfailedtobe
effective. Not only does NHE inhibition appear to adversely affect
multiple cellular components by decreasing pH, but it may be the
case that NHE inhibition alone is not sufficient and that ATP
manipulation is a more effective approach.
Earlier it was noted that there are several possible reasons for
the failure thus far in developing an effective therapy for the
treatment of ischemia-reperfusion injury. Within the context of
NHE inhibition, it is important to remember that many of the
subjects involved in clinical trials are afflicted with conditions such
as cardiac hypertrophy and heart failure. There is evidence linking
increased NHE activity to heart failure, both in the clinical setting
and in experimental models [35]. In addition, there is evidence
suggesting that NHE inhibition therapy can reverse cardiac
hypertrophy in animal models. It is reasonable to expect that, in
diseased cardiomyocytes with increased NHE activity, this
exchanger would play a more prominent role in sodium and pH
regulation. This may prove to be a liability for patients afflicted
with heart failure if the conclusions of this study are true.
The preceding discussion concerning sodium and calcium
overload has been of a qualitative nature, but a logical followup
question is exactly how much sodium and/or calcium overload is
pathological? This is a difficult question to answer, as it likely
depends on the state of many other components in the cell [38]. In
addition, profiles of experimentally measured sodium and calcium
concentrations in ischemic and reperfused myocardium vary
depending on experimental technique [33] and species, among
other factors. However, some light can be shed by examining
recent results examining relationships between sodium, calcium,
and cardiac dysfunction in guinea pig cells [39]. In this study,
ouabain was used to inhibit NaK function, resulting in elevated
intracellular sodium concentrations. When cells were paced at a
rate of 1 Hz, [Naz
i ] rose to a concentration of approximately
8 mM within 5 minutes of ouabain treatment at a concentration
of 0.1 uM, and remained at about 8 mM for the rest of the
experiment. When a concentration of 0.5 uM was used, [Naz
i ]
reached a concentration between 8 and 9 mM within 5 minutes,
further climbing to a concentration of about 15 mM 3 minutes
later. Further experiments were performed using ouabain at a
concentration of 0.25 uM, so the sodium concentrations in these
experiments were likely between 8 and 15 mM. In the same study,
peak systolic calcium concentrations reached approximately 2.5
and 3 uM 5 and 8 minutes after 0.25 uM ouabain treatment,
respectively (compared to approximately 1.4 uM in control). At
the same time, the probability of an action potential being
triggered by a delayed afterdepolarization was in excess of 0.3
(compared to less than 0.1 for control), the rate of oxygen
consumption nearly doubled, and reduced NADH availability fell
to approximately one-third of control levels.
Table 6. Proportion of total number of sodium moles moved.
Control R50 R0 M50 M0 I50 I0
NHE 0.041 0.029 0.000 0.028 0.000 0.028 0.000
NBC 0.014 0.019 0.034 0.018 0.032 0.018 0.033
NCX 0.293 0.297 0.302 0.302 0.319 0.302 0.320
NaK 0.471 0.469 0.465 0.468 0.458 0.468 0.457
INa 0.065 0.067 0.071 0.066 0.066 0.066 0.066
INa,l 0.004 0.004 0.004 0.004 0.004 0.004 0.004
INa,b 0.073 0.075 0.081 0.074 0.077 0.074 0.077
ICa(L),Na 0.039 0.040 0.043 0.040 0.043 0.040 0.043
doi:10.1371/journal.pcbi.1002241.t006
Ischemia-Reperfusion Modeling and NHE Inhibition
PLoS Computational Biology | www.ploscompbiol.org 16 October 2011 | Volume 7 | Issue 10 | e1002241Ischemia-Reperfusion Modeling and NHE Inhibition
PLoS Computational Biology | www.ploscompbiol.org 17 October 2011 | Volume 7 | Issue 10 | e1002241Again, these numbers provide only a rough guide, and the
results of the ouabain study did not occur in the setting of true
ischemia. However, what we found particularly interesting in the
present study was that at best NHE inhibition resulted in a very
small improvement in peak [Naz
i ] during reperfusion (less than 1
percent), and that this adverse outcome was the result of inhibiting
intracellular pH recovery.
Limitations
The model presented here was used for the simulation of
abrupt, complete stop-flow ischemia and abrupt-onset reperfusion.
However, with some relatively simple modifications to the
simulation protocols, it is possible to simulate ischemia of varying
severity and following different time courses (e.g. episodes of
ischemia punctuated with intervals of reperfusion).
This model is by no means an attempt to capture all of the
mechanisms of ischemic pathophysiology. For example, INa
[40,41] and ICa(L) [41,42] have been reported to be modified by
acidosis. However, these sensitivities are not represented in the
model, as they did not change model performance in a significant
way and because of possible confounding factors in the
experimental evidence with regard to the ICa(L) data. A discussion
of the issues relating to the ICa(L) current can be found in [8,43].
Also, there has been work centered around the role of other
components and processes in the development of reperfusion
arrhythmias (for example, see [44] and [45]). Explicit mitochon-
drial physiology would be an interesting addition to the model,
particularly in the context of mitochondrial NHE function and
proton and calcium homeostasis. In the current version of the
model, the equations dictating phosphometabolite concentrations
serve as a proxy for mitochondrial failure, a choice we made based
upon computational time considerations. However, we expect to
incorporate more detailed mitochondrial physiology in the future.
Despite the many facets of ischemia physiology that are not
included in our model, we believe that it is an important step
towards a comprehensive ischemia-reperfusion model, and one
that reproduces electrical and chemical changes that have been
seen in vitro. Reactive oxygen species generation is also believed to
play a major role, as is apoptosis. These will be interesting
potential additions in the future once suitable mathematical
representations are devised, especially if longer reperfusion times
are to be modeled, where apoptosis likely plays a more significant
role.
Comparison of our simulation results with experimental data in
Figure 4 reveals some discrepancies in behavior. The level of
extracellular acidosis produced by our model under these
simulation conditions is more profound than what is typically
observed. In addition, the initial conditions and parameters that
we have chosen yield higher sodium concentrations during
ischemia and a slower rate of sodium accumulation during
reperfusion than observed in the cited experiment. These are the
result of choices we have made in tuning many parameters to fit
data from many different groups, performed under different
conditions and at different points in time. For example, an
improved match to the cited sodium data can be achieved with the
model, but at the expense of a decreased fit to extracellular pH
and potassium data. While there is still room for improvement, we
believe that this model provides a good fit to phenomena that
occur during myocardial reperfusion and can yield useful insight
into this complex problem.
Many calcium-handling components are sensitive to changes in
cellular pH, and some of these relationships are represented in our
model. In addition, our model includes ATP-dependencies of
components that directly and indirectly affect sodium and calcium
balance, such as the NaK, SERCA, and ATP-inactivated
potassium efflux channels. The importance of these influences
have been alluded to above and are being explored in current
work.
Conclusion
The pathophysiology of ischemia-reperfusion injury is very
complex, taking place within the context of a system that is highly
coupled with nonlinear relationships between many of the
components. Because such systems frequently exhibit nonintuitive
behavior, we believe that the model developed in this study will
prove useful in illuminating underlying mechanisms. For example,
here we have used the model to propose a possible explanation for
why NHE inhibition, a seemingly straightforward approach to
limiting sodium-mediated reperfusion injury, has shown no
meaningful clinical efficacy to date, and what efficacy has been
observed requires the administration of NHE blockers prior to the
onset of ischemia. Our investigations indicate that NHE inhibition
can paradoxically exacerbate sodium and calcium overload. NHE
inhibition suppresses intracellular pH recovery during reperfusion,
which decreases the ability of the sodium-potassium exchanger to
remove sodium from the cell and favors influx of sodium through
the sodium-bicarbonate symporter. Most of any observed benefit
of NHE inhibition appears to come from decreased sodium load
resulting from reduced NHE activity prior to the onset of
ischemia. Suppressing pH recovery during reperfusion is also
likely to negatively impact other cellular systems, such as those
responsible for handling calcium, that we have not examined here.
Supporting Information
Text S1 Contains names and constant values (where applicable)
for all model variables, all model equations, additional information
Figure 8. Removing pH-induced inhibition of sodium-potassium exchange decreases sodium and calcium overload during
simulated reperfusion. Ischemic phase of simulations denoted by gray shading. The three simulations shown are: Control (with no NHE inhibition)
(black), R0 (complete NHE block instituted at the beginning of reperfusion) (green), and R0, but with the NaK responding to a normal pH as opposed
to an acidotic pH being sensed by the rest of the subcellular components (gray). Intracellular sodium concentrations are shown in (A), maximum and
minimum intracellular calcium concentrations are shown in (B), and maximum and minimum current through the sodium-potassium exchanger
(INaK) during each beat are shown in (C). If the sodium-potassium exchanger is not inhibited by intracellular acidosis, significant reductions in sodium
and calcium overload during reperfusion are observed, due to increased ability of the exchanger to remove sodium from the cell. The left inset in (C)
shows INaK over 150 ms, plotted on the same vertical axis as the main figure, during the last beat prior to the onset of ischemia. The right inset
shows current traces, on the same scale, during the last beat of the simulation.
doi:10.1371/journal.pcbi.1002241.g008
Table 7. Intracellular bicarbonate.
Control R50 R0 M50 M0 I50 I0
End HCO
{
3,i 6.85 6.37 5.53 6.44 5.97 6.44 5.97
Mean HCO
{
3,i 5.72 5.22 4.32 5.40 5.03 5.41 4.98
Concentrations in mM.
doi:10.1371/journal.pcbi.1002241.t007
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summary of the ischemia-reperfusion simulation protocol, and
additional figures pertaining to simulations relevant to model
validation.
(PDF)
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